These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11870523

  • 1. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.
    Rofstad EK, Halsør EF.
    Br J Cancer; 2002 Jan 21; 86(2):301-8. PubMed ID: 11870523
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
    Rofstad EK, Danielsen T.
    Br J Cancer; 1999 Aug 21; 80(11):1697-707. PubMed ID: 10468285
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 4. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.
    Cancer Res; 2005 Mar 15; 65(6):2387-96. PubMed ID: 15781654
    [Abstract] [Full Text] [Related]

  • 5. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.
    Rofstad EK, Gaustad JV, Egeland TA, Mathiesen B, Galappathi K.
    Int J Cancer; 2010 Oct 01; 127(7):1535-46. PubMed ID: 20091868
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
    Rofstad EK, Danielsen T.
    Br J Cancer; 1998 Mar 01; 77(6):897-902. PubMed ID: 9528831
    [Abstract] [Full Text] [Related]

  • 7. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.
    Westphal JR, van't Hullenaar RG, van der Laak JA, Cornelissen IM, Schalkwijk LJ, van Muijen GN, Wesseling P, de Wilde PC, Ruiter DJ, de Waal RM.
    Br J Cancer; 1997 Mar 01; 76(5):561-70. PubMed ID: 9303353
    [Abstract] [Full Text] [Related]

  • 8. The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts.
    Danielsen T, Rofstad EK.
    Br J Cancer; 2000 May 01; 82(9):1528-34. PubMed ID: 10789719
    [Abstract] [Full Text] [Related]

  • 9. Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.
    Rofstad EK, Mathiesen B.
    Neoplasia; 2010 Nov 01; 12(11):889-98. PubMed ID: 21076614
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
    Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA.
    Cancer Res; 2002 Mar 15; 62(6):1847-53. PubMed ID: 11912164
    [Abstract] [Full Text] [Related]

  • 11. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F, Farao M, Ciomei M, Pastori A, Mongelli N, Grandi M.
    Invasion Metastasis; 1995 Mar 15; 15(5-6):222-31. PubMed ID: 8765197
    [Abstract] [Full Text] [Related]

  • 12. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr 15; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 15; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.
    Clin Cancer Res; 2000 Dec 15; 6(12):4874-84. PubMed ID: 11156247
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr 15; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
    Erhard H, Rietveld FJ, van Altena MC, Bröcker EB, Ruiter DJ, de Waal RM.
    Melanoma Res; 1997 Aug 15; 7 Suppl 2():S19-26. PubMed ID: 9578413
    [Abstract] [Full Text] [Related]

  • 20. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marmé D, Martiny-Baron G.
    Cancer Res; 1999 Jul 01; 59(13):3185-91. PubMed ID: 10397264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.